Increased Adipose Tissue Expression of Hepcidin in Severe Obesity Is Independent From Diabetes and NASH

Gastroenterology

Volumn 131, Issue 3, 2006, Pages 788-796

  Bekri, Soumeya ^a   Gual, Philippe ^b   Anty, Rodolphe ^a,b,c   Luciani, Nathalie ^a   Dahman, Monsef ^c   Ramesh, Bala ^d   Iannelli, Antonio ^c   Staccini Myx, Aline ^c   Casanova, Dominique ^e   Ben Amor, Imed ^c   Saint Paul, Marie Christine ^c   Huet, Pierre Michel ^c   Sadoul, Jean Louis ^c   Gugenheim, Jean ^c   Srai, Surjit Kaila S ^d   Tran, Albert ^a,c   Le Marchand Brustel, Yannick ^b  

^a UNIVERSITÉ CÔTE D'AZUR   (France)

^b INSERM   (France)

^c UNIVERSITY HOSPITAL OF NICE   (France)

^d ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^e HÔPITAL DE LA CONCEPTION   (France)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HEPCIDIN; INTERLEUKIN 6; IRON; MESSENGER RNA; TRANSFERRIN;

ADIPOSE TISSUE; ADULT; ANEMIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; EXPLANT; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; INFLAMMATION; IRON ABSORPTION; LIVER; MACROPHAGE; MALE; NONALCOHOLIC FATTY LIVER; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 33748265283     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2006.07.007     Document Type: Article

References (43)

1. Yudkin J.S., Stehouwer C.D., Emeis J.J., and Coppack S.W. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?. Arterioscler Thromb Vasc Biol 19 (1999) 972-878
2. Mohamed-Ali V., Goodrick S., Rawesh A., Katz D.R., Miles J.M., Yudkin J.S., Klein S., and Coppack S.W. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-α, in vivo. J Clin Endocrinol Metab 82 (1997) 4196-4200
3. Dandona P., Aljada A., and Bandyopadhyay A. Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol 25 (2004) 4-7
4. Alessi M.C., Bastelica D., Morange P., Berthet B., Leduc I., Verdier M., Geel O., and Juhan-Vague I. Plasminogen activator inhibitor 1, transforming growth factor-β1, and BMI are closely associated in human adipose tissue during morbid obesity. Diabetes 49 (2000) 1374-1380
5. Lundgren C.H., Brown S.L., Nordt T.K., Sobel B.E., and Fujii S. Elaboration of type-1 plasminogen activator inhibitor from adipocytes. A potential pathogenetic link between obesity and cardiovascular disease. Circulation 93 (1996) 106-110
6. Trayhurn P., and Wood I.S. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 92 (2004) 347-355
7. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., and Ferrante Jr. A.W. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112 (2003) 1796-1808
8. Xu H., Barnes G.T., Yang Q., Tan G., Yang D., Chou C.J., Sole J., Nichols A., Ross J.S., Tartaglia L.A., and Chen H. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112 (2003) 1821-1830
9. Grimble R.F. Inflammatory status and insulin resistance. Curr Opin Clin Nutr Metab Care 5 (2002) 551-559
10. Park C.H., Valore E.V., Waring A.J., and Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 276 (2001) 7806-7810
11. Fleming R.E., and Sly W.S. Hepcidin: a putative iron-regulatory hormone relevant to hereditary hemochromatosis and the anemia of chronic disease. Proc Natl Acad Sci U S A 98 (2001) 8160-8162
12. Knutson M.D., Oukka M., Koss L.M., Aydemir F., and Wessling-Resnick M. Iron release from macrophages after erythrophagocytosis is up-regulated by ferroportin 1 overexpression and down-regulated by hepcidin. Proc Natl Acad Sci U S A 102 (2005) 1324-1328
13. Nemeth E., Tuttle M.S., Powelson J., Vaughn M.B., Donovan A., Ward D.M., Ganz T., and Kaplan J. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306 (2004) 2090-2093
14. Yeh K.Y., Yeh M., and Glass J. Hepcidin regulation of ferroportin 1 expression in the liver and intestine of the rat. Am J Physiol Gastrointest Liver Physiol 286 (2004) G385-G394
15. Laftah A.H., Ramesh B., Simpson R.J., Solanky N., Bahram S., Schumann K., Debnam E.S., and Srai S.K. Effect of hepcidin on intestinal iron absorption in mice. Blood 103 (2004) 3940-3944
16. Yamaji S., Sharp P., Ramesh B., and Srai S.K. Inhibition of iron transport across human intestinal epithelial cells by hepcidin. Blood 104 (2004) 2178-2180
17. Pigeon C., Ilyin G., Courselaud B., Leroyer P., Turlin B., Brissot P., and Loreal O. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 276 (2001) 7811-7819
18. Nicolas G., Chauvet C., Viatte L., Danan J.L., Bigard X., Devaux I., Beaumont C., Kahn A., and Vaulont S. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest 110 (2002) 1037-1044
19. Nemeth E., Valore E.V., Territo M., Schiller G., Lichtenstein A., and Ganz T. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 101 (2003) 2461-2463
20. Lee P., Peng H., Gelbart T., and Beutler E. The IL-6- and lipopolysaccharide-induced transcription of hepcidin in HFE-, transferrin receptor 2-, and β 2-microglobulin-deficient hepatocytes. Proc Natl Acad Sci U S A 101 (2004) 9263-9265
21. Nemeth E., Rivera S., Gabayan V., Keller C., Taudorf S., Pedersen B.K., and Ganz T. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 113 (2004) 1271-1276
22. Roy C.N., Custodio A.O., de Graaf J., Schneider S., Akpan I., Montross L.K., Sanchez M., Gaudino A., Hentze M.W., Andrews N.C., and Muckenthaler M.U. An Hfe-dependent pathway mediates hyposideremia in response to lipopolysaccharide-induced inflammation in mice. Nat Genet 36 (2004) 481-485
23. Nieken J., Mulder N.H., Buter J., Vellenga E., Limburg P.C., Piers D.A., and de Vries E.G. Recombinant human interleukin-6 induces a rapid and reversible anemia in cancer patients. Blood 86 (1995) 900-905
24. Means Jr. R.T. Hepcidin and anaemia. Blood Rev 18 (2004) 219-225
25. Brunt E.M. Grading and staging the histopathological lesions of chronic hepatitis: the Knodell histology activity index and beyond. Hepatology 31 (2000) 241-246
26. Scheuer P., and Lefkowitch J. Liver biopsy interpretation (1994), Saunders, Philadelphia
27. Anty R., Bekri S., Luciani N., Saint-Paul M., Dahman M., Iannelli A., Ben Amor I., Staccini-Myx A., Huet P., Gugenheim J., Sadoul J., Le Marchand-Brustel Y., Tran A., and Gual P. The inflammatory C-reactive protein is increased in both liver and adipose tissue in severely obese patients independently from metabolic syndrome, type 2 diabetes, and NASH. Am J Gastroenterol (2006) (in press).
28. Gabrielsson B.G., Olofsson L.E., Sjogren A., Jernas M., Elander A., Lonn M., Rudemo M., and Carlsson L.M. Evaluation of reference genes for studies of gene expression in human adipose tissue. Obes Res 13 (2005) 649-652
29. Schmid-Alliana A., Menou L., Manie S., Schmid-Antomarchi H., Millet M.A., Giuriato S., Ferrua B., and Rossi B. Microtubule integrity regulates src-like and extracellular signal-regulated kinase activities in human pro-monocytic cells. Importance for interleukin-1 production. J Biol Chem 273 (1998) 3394-3400
30. Kallen K.J. The role of transsignalling via the agonistic soluble IL-6 receptor in human diseases. Biochim Biophys Acta 1592 (2002) 323-343
31. Schobitz B., Pezeshki G., Pohl T., Hemmann U., Heinrich P.C., Holsboer F., and Reul J.M. Soluble interleukin-6 (IL-6) receptor augments central effects of IL-6 in vivo. FASEB J 9 (1995) 659-664
32. Liu X.B., Nguyen N.B., Marquess K.D., Yang F., and Haile D.J. Regulation of hepcidin and ferroportin expression by lipopolysaccharide in splenic macrophages. Blood Cells Mol Dis 35 (2005) 47-56
33. Clement K., Viguerie N., Poitou C., Carette C., Pelloux V., Curat C.A., Sicard A., Rome S., Benis A., Zucker J.D., Vidal H., Laville M., Barsh G.S., Basdevant A., Stich V., Cancello R., and Langin D. Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects. FASEB J 18 (2004) 1657-1669
34. Frazer D.M., Wilkins S.J., Millard K.N., McKie A.T., Vulpe C.D., and Anderson G.J. Increased hepcidin expression and hypoferraemia associated with an acute phase response are not affected by inactivation of HFE. Br J Haematol 126 (2004) 434-436
35. Lee P., Peng H., Gelbart T., Wang L., and Beutler E. Regulation of hepcidin transcription by interleukin-1 and interleukin-6. Proc Natl Acad Sci U S A 102 (2005) 1906-1910
36. Aldhahi W., and Hamdy O. Adipokines, inflammation, and the endothelium in diabetes. Curr Diabetes Rep 3 (2003) 293-298
37. Rivera S., Nemeth E., Gabayan V., Lopez M.A., Farshidi D., and Ganz T. Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportin-containing organs. Blood 106 (2005) 2196-2199
38. Frazer D.M., and Anderson G.J. The orchestration of body iron intake: how and where do enterocytes receive their cues?. Blood Cells Mol Dis 30 (2003) 288-297
39. Bugianesi E., Manzini P., D'Antico S., Vanni E., Longo F., Leone N., Massarenti P., Piga A., Marchesini G., and Rizzetto M. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver. Hepatology 39 (2004) 179-187
40. Wenzel B.J., Stults H.B., and Mayer J. Hypoferraemia in obese adolescents. Lancet 2 (1962) 327-328
41. Seltzer C.C., Wenzel B.J., and Mayer J. Serum iron and iron-binding capacity in adolescents. I. Standard values. Am J Clin Nutr 13 (1963) 343-353
42. Pinhas-Hamiel O., Newfield R.S., Koren I., Agmon A., Lilos P., and Phillip M. Greater prevalence of iron deficiency in overweight and obese children and adolescents. Int J Obes Relat Metab Disord 27 (2003) 416-418
43. Nead K.G., Halterman J.S., Kaczorowski J.M., Auinger P., and Weitzman M. Overweight children and adolescents: a risk group for iron deficiency. Pediatrics 114 (2004) 104-108